The evolution of catheter ablation for the treatment of supraventricul
ar tachycardias represents a major advance in the management of cardia
c arrhythmias. Excellent results in the majority of patients undergoin
g the procedure, together with a low rate of early complications and a
brief hospitalization, make catheter ablation a highly cost-effective
permanent cure. At present, however, its place in relation to alterna
te therapies in the management of supraventricular tachycardias has no
t been clearly established owing to unresolved risk-benefit issues, Co
ntinuing technical advances will likely enable catheter ablation to be
successfully applied to a broader range of cardiac arrhythmias.